Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 185.70 EUR | -0.91% |
|
+1.31% | -11.57% |
| 07-16 | MedTech facing a three-front squeeze |  |
| 07-13 | SARTORIUS STEDIM BIOTECH : UBS reiterates its Neutral rating | ZD |
| Market Cap | 18.07B 20.68B 16.67B 15.37B 28.97B 1,991B 29.61B 199B 78.38B 975B 77.65B 75.94B 3,357B | P/E 2026 * |
47.2x | P/E 2027 * | 37.1x |
|---|---|---|---|---|---|
| Enterprise Value | 20.08B 22.98B 18.53B 17.08B 32.19B 2,213B 32.91B 221B 87.11B 1,084B 86.29B 84.4B 3,731B | EV / Sales 2026 * |
6.34x | EV / Sales 2027 * | 5.68x |
| Free-Float |
28.47% | Yield 2026 * |
0.46% | Yield 2027 * | 0.55% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | -0.91% | ||
| 1 week | +1.31% | ||
| Current month | +2.26% | ||
| 1 month | +5.09% | ||
| 3 months | -1.59% | ||
| 6 months | -12.94% | ||
| Current year | -11.57% |
| 1 week | 181.4 |  | 190.8 |
| 1 month | 160.4 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 287.8 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.91% | +1.31% | -3.73% | -18.94% | 20.68B | |
| +1.87% | +7.19% | -16.46% | -5.91% | 175B | |
| -0.43% | -0.80% | -7.07% | -4.05% | 106B | |
| -0.03% | +1.47% | +4.59% | +60.25% | 59.91B | |
| +0.66% | +0.96% | +37.56% | +53.38% | 51.95B | |
| -1.10% | +4.10% | -12.56% | -38.37% | 43.58B | |
| -3.21% | -3.05% | - | - | 33.65B | |
| -1.71% | +2.25% | -8.86% | -44.23% | 29.58B | |
| -1.16% | +1.28% | +61.67% | -6.62% | 25.31B | |
| -1.49% | +0.85% | -3.01% | -4.60% | 21.23B | |
| Average | -0.75% | +1.56% | +5.79% | -1.01% | 56.77B | |
| Weighted average by Cap. | +0.05% | +2.70% | -1.50% | +2.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.17B 3.62B 2.92B 2.69B 5.07B 349B 5.19B 34.91B 13.73B 171B 13.6B 13.3B 588B | 3.5B 4B 3.23B 2.97B 5.6B 385B 5.73B 38.55B 15.16B 189B 15.02B 14.69B 649B |
| Net income | 380M 435M 351M 323M 609M 41.89B 623M 4.19B 1.65B 20.51B 1.63B 1.6B 70.62B | 475M 543M 438M 404M 761M 52.33B 778M 5.24B 2.06B 25.63B 2.04B 2B 88.23B |
| Net Debt | 2.01B 2.3B 1.86B 1.71B 3.23B 222B 3.3B 22.2B 8.73B 109B 8.65B 8.46B 374B | 1.77B 2.02B 1.63B 1.5B 2.83B 195B 2.9B 19.5B 7.67B 95.42B 7.6B 7.43B 328B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | €185.70 | -0.91% | 107,069 |
| 26-07-16 | €187.40 | -0.85% | 65,344 |
| 26-07-15 | €189.00 | +0.27% | 52,185 |
| 26-07-14 | €188.50 | -0.42% | 69,084 |
| 26-07-13 | €189.30 | +3.27% | 80,797 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
